BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6127478)

  • 1. Charcoal hemoperfusion for liver failure.
    Weston MJ
    Lancet; 1982 Oct; 2(8305):983. PubMed ID: 6127478
    [No Abstract]   [Full Text] [Related]  

  • 2. Clinical experience with charcoal and resin hemoperfusion.
    Hughes R; Williams R
    Semin Liver Dis; 1986 May; 6(2):164-73. PubMed ID: 3018936
    [No Abstract]   [Full Text] [Related]  

  • 3. [Complications and side effects of hemoperfusion].
    Amano I; Inagaki Y
    Nihon Rinsho; 1991 Dec; 49 Suppl():649-54. PubMed ID: 1808331
    [No Abstract]   [Full Text] [Related]  

  • 4. The use of prostacyclin, PGI2, in the prevention of platelet aggregation during charcoal haemoperfusion.
    Langley PG; Hughes RD; Ton HY; Silk DB; Williams R
    Int J Artif Organs; 1979 Jul; 2(4):207-10. PubMed ID: 378864
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Hemoperfusion across charcoal in acute hepatic failure in the dog].
    Horák J; Horký J; Rábl M
    Cesk Gastroenterol Vyz; 1980 Mar; 34(2):86-95. PubMed ID: 7388982
    [No Abstract]   [Full Text] [Related]  

  • 6. Earlier charcoal haemoperfusion in fulminant hepatic failure.
    Gimson AE; Braude S; Mellon PJ; Canalese J; Williams R
    Lancet; 1982 Sep; 2(8300):681-3. PubMed ID: 6126626
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Current concepts of hemoperfusion through activated charcoal in the treatment of internal diseases].
    Dmitriev AA
    Ter Arkh; 1983; 55(6):140-8. PubMed ID: 6351328
    [No Abstract]   [Full Text] [Related]  

  • 8. Influence of hemoperfusion using coated bead-type charcoal on middle molecules of hepatic failure dogs.
    Nishiki M; Kawanishi H; Kanao M; Sugiyama M; Tsuchiya T; Ezaki H
    Hiroshima J Med Sci; 1984 Sep; 33(3):493-7. PubMed ID: 6511475
    [No Abstract]   [Full Text] [Related]  

  • 9. [Clinical results of charcoal hemoperfusion: studies of 55 cases extending over 250 incidents].
    Agishi T; Yamashita N; Ota K
    Nihon Rinsho; 1980 Dec; 38(12):4697-702. PubMed ID: 7253246
    [No Abstract]   [Full Text] [Related]  

  • 10. Basic study of polyetherurethane coated bead-type activated charcoal for direct hemoperfusion.
    Kawanishi H; Nishiki M; Sugiyama M; Cho T; Tsuchiya T; Ezaki H
    Hiroshima J Med Sci; 1983 Mar; 32(1):9-14. PubMed ID: 6863016
    [No Abstract]   [Full Text] [Related]  

  • 11. Haemoperfusion through activated carbon adsorbents in liver failure and hepatic coma.
    Bartels O
    Acta Hepatogastroenterol (Stuttg); 1978 Aug; 25(4):324-9. PubMed ID: 696211
    [No Abstract]   [Full Text] [Related]  

  • 12. Platelet function in fulminant hepatic failure and effect of charcoal haemoperfusion.
    Weston MJ; Langley PG; Rubin MH; Hanid MA; Mellon P; Williams R
    Gut; 1977 Nov; 18(11):897-902. PubMed ID: 590850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The development of a new hemoperfusion column: the filmadsorber.
    van Berlo A; Verkooyen A; Tangerman A
    Int J Artif Organs; 1982 May; 5(3):181-4. PubMed ID: 7107054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neutrophil adherence during hemoperfusion in fulminant hepatic failure.
    Altin M; Hughes RD; Williams R
    Int J Artif Organs; 1982 Sep; 5(5):315-7. PubMed ID: 7174138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Experience in using hemosorption in treating liver failure].
    Skiba VV; Voĭtenko GH; Kolesnikov EB; Zubkov VI; Bondarevskaia TM
    Klin Med (Mosk); 1980 Apr; 58(4):87-90. PubMed ID: 7382374
    [No Abstract]   [Full Text] [Related]  

  • 16. Clinical experience with the use of charcoal haemoperfusion: is prostacyclin required?
    Kennedy HJ; Greaves M; Triger DR
    Life Support Syst; 1985; 3(2):115-22. PubMed ID: 3894813
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Trials and tribulations with artificial liver support.
    Williams R
    Gut; 1978 Jun; 19(6):578-83. PubMed ID: 355070
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of prostacyclin in extracorporeal circulation.
    Ede RJ; Hughes RD; Williams R
    Int J Artif Organs; 1985 Nov; 8(6):297-300. PubMed ID: 3908327
    [No Abstract]   [Full Text] [Related]  

  • 19. Effects of hemoperfusion rate and time of initiation of ACAC charcoal hemoperfusion on the survival of fulminant hepatic failure rats.
    Chang TM; Lister C; Chirito E; O'Keefe P; Resurreccion E
    Trans Am Soc Artif Intern Organs; 1978; 24():243-5. PubMed ID: 716006
    [No Abstract]   [Full Text] [Related]  

  • 20. Hemoperfusion: state of the art and future requirements.
    Sideman S; Chang TM
    Artif Organs; 1980 Feb; 4(1):70-5. PubMed ID: 7369897
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.